Table 1 Characteristics of the included studies
Author | Publication year | Region | Duration time | Survival outcome | cutoff | Median follow-up(IQR)/months | Average age(IQR)/years | Study design | Sample size | NOS |
|---|---|---|---|---|---|---|---|---|---|---|
Jiang et al. [27] | 2021 | Asia | 2016–2019 | OS、PFS | 3 | NR | 73.4(70.3–76.5) | cohort | 41 | 7 |
Man et al. [24] | 2019 | Asia | 2010–2018 | OS | 3 | 24(2-118) | 70 (51–88) | cohort | 179 | 6 |
Bello et al. [23] | 2019 | Africa | 2013–2017 | OS | 1.8 | 12 | 69(62–76) | cohort | 58 | 9 |
Wu et al. [22] | 2018 | Asia | 2009–2016 | OS | 3.3 | NR | 71(53–85) | cohort | 71 | 9 |
Pei et al. [21] | 2017 | Asia | 2009–2016 | OS、PFS | 3.3 | 16(1–50) | 71 (43–86) | cohort | 111 | 9 |
Buttigliero et al. [20] | 2017 | Europe | 2004–2016 | OS、PFS | 3 | 31.7 | 68 (48–85) | cohort | 179 | 8 |
Yao et al. [19] | 2015 | Asia | 2009–2014 | OS、PFS | 3.5 | 19 (1–61) | 74 (55–91) | cohort | 57 | 7 |
Templeton et al. [18] | 2014 | North America | 2001–2011 | OS | 3 | 15 | 71(44–90) | cohort | 357 | 7 |
Nuhn et al. [17] | 2014 | North America | 1998–2010 | OS | 3 | 15.0(1.5–90.2) | 68.3(44.6–84.5) | cohort | 238 | 7 |
Kobayashi et al. [28] | 2022 | Asia | 2008–2018 | OS、PFS | 2.9 | NR | 71 (66–76) | cohort | 95 | 9 |
Stangl-Kremser et al. [26] | 2020 | Europe | 2005–2016 | OS | 3 | 25.5(12.8 − 42.4) | 68.8(64.6 − 75.0) | cohort | 186 | 7 |
Linton et al. [16] | 2013 | North America Europe | 2007–2009 | OS | 5 | NR | NR | cohort | 220 | 7 |
Neuberger et al. [29] | 2022 | Europe | 2010–2019 | OS | 3 | 18.5(10.8–36.5) | 72(65–76) | cohort | 118 | 6 |
Tatenuma et al. [25] | 2019 | Asia | NR | OS | 2.59 | 21(2–51) | 72(63.6–77) | cohort | 73 | 9 |